APO Research

APO RESEARCH · REPORT

Chinese Medicine Injection for Nervous Diseases

Selected research

Industry Research

Chinese Medicine Injection for Nervous Diseases Industry Research Report 2026

Market perspective

The global Chinese Medicine Injection for Nervous Diseases market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Chinese Medicine Injection for Nervous Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Chinese Medicine Injection for Nervous Diseases is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Chinese Medicine Injection for Nervous Diseases is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Chinese Medicine Injection for Nervous Diseases include ZBD Pharmaceutical, Yunnan Biovalley Pharmaceutical, Wuzhou Pharmaceutical, Tasly Pharmaceuticals, Shenyang Shuangding Pharmaceutical, Mudanjiang Youbo Pharmaceutical, Kunming Longjin Pharmaceutical, Kanion Pharmaceutical and Jinling Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Chinese Medicine Injection for Nervous Diseases market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Chinese Medicine Injection for Nervous Diseases Market by Company

ZBD Pharmaceutical

Yunnan Biovalley Pharmaceutical

Wuzhou Pharmaceutical

Tasly Pharmaceuticals

Shenyang Shuangding Pharmaceutical

Mudanjiang Youbo Pharmaceutical

Kunming Longjin Pharmaceutical

Kanion Pharmaceutical

Jinling Pharmaceutical

Jemincare

Heilongjiang Wusulijiang Pharmaceutical

Chengdu Baiyu Pharmaceutical

Buchang Pharmaceutical

Chinese Medicine Injection for Nervous Diseases Segment by Type

Xueshuantong Injection (Lyophilized)

Xuesetong Injection (Lyophilized)

Ginkgo Biloba Diterpenoids Meglumine Injection

Xingnaojing Injection

Shuxuetong Injection

Danhong Injection

Acanthopanax Senticosus Injection

Other

Chinese Medicine Injection for Nervous Diseases Segment by Application

Secondary Hospital

Tertiary Hospital

Other

Chinese Medicine Injection for Nervous Diseases Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chinese Medicine Injection for Nervous Diseases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chinese Medicine Injection for Nervous Diseases and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chinese Medicine Injection for Nervous Diseases.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Chinese Medicine Injection for Nervous Diseases manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Chinese Medicine Injection for Nervous Diseases by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Chinese Medicine Injection for Nervous Diseases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Chinese Medicine Injection for Nervous Diseases Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Chinese Medicine Injection for Nervous Diseases Sales (k units) of Manufacturers (2021-2026) Table 7. Global Chinese Medicine Injection for Nervous Diseases Sales Market Share by Manufacturers (2021-2026) Table 8. Global Chinese Medicine Injection for Nervous Diseases Revenue of Manufacturers (2021-2026) Table 9. Global Chinese Medicine Injection for Nervous Diseases Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Chinese Medicine Injection for Nervous Diseases Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Chinese Medicine Injection for Nervous Diseases Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Chinese Medicine Injection for Nervous Diseases, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Chinese Medicine Injection for Nervous Diseases, Product Type & Application Table 14. Global Chinese Medicine Injection for Nervous Diseases Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Chinese Medicine Injection for Nervous Diseases by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. ZBD Pharmaceutical Company Information Table 19. ZBD Pharmaceutical Business Overview Table 20. ZBD Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. ZBD Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 22. ZBD Pharmaceutical Recent Developments Table 23. Yunnan Biovalley Pharmaceutical Company Information Table 24. Yunnan Biovalley Pharmaceutical Business Overview Table 25. Yunnan Biovalley Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Yunnan Biovalley Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 27. Yunnan Biovalley Pharmaceutical Recent Developments Table 28. Wuzhou Pharmaceutical Company Information Table 29. Wuzhou Pharmaceutical Business Overview Table 30. Wuzhou Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Wuzhou Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 32. Wuzhou Pharmaceutical Recent Developments Table 33. Tasly Pharmaceuticals Company Information Table 34. Tasly Pharmaceuticals Business Overview Table 35. Tasly Pharmaceuticals Chinese Medicine Injection for Nervous Diseases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Tasly Pharmaceuticals Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 37. Tasly Pharmaceuticals Recent Developments Table 38. Shenyang Shuangding Pharmaceutical Company Information Table 39. Shenyang Shuangding Pharmaceutical Business Overview Table 40. Shenyang Shuangding Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Shenyang Shuangding Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 42. Shenyang Shuangding Pharmaceutical Recent Developments Table 43. Mudanjiang Youbo Pharmaceutical Company Information Table 44. Mudanjiang Youbo Pharmaceutical Business Overview Table 45. Mudanjiang Youbo Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Mudanjiang Youbo Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 47. Mudanjiang Youbo Pharmaceutical Recent Developments Table 48. Kunming Longjin Pharmaceutical Company Information Table 49. Kunming Longjin Pharmaceutical Business Overview Table 50. Kunming Longjin Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Kunming Longjin Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 52. Kunming Longjin Pharmaceutical Recent Developments Table 53. Kanion Pharmaceutical Company Information Table 54. Kanion Pharmaceutical Business Overview Table 55. Kanion Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Kanion Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 57. Kanion Pharmaceutical Recent Developments Table 58. Jinling Pharmaceutical Company Information Table 59. Jinling Pharmaceutical Business Overview Table 60. Jinling Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Jinling Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 62. Jinling Pharmaceutical Recent Developments Table 63. Jemincare Company Information Table 64. Jemincare Business Overview Table 65. Jemincare Chinese Medicine Injection for Nervous Diseases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Jemincare Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 67. Jemincare Recent Developments Table 68. Heilongjiang Wusulijiang Pharmaceutical Company Information Table 69. Heilongjiang Wusulijiang Pharmaceutical Business Overview Table 70. Heilongjiang Wusulijiang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Heilongjiang Wusulijiang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 72. Heilongjiang Wusulijiang Pharmaceutical Recent Developments Table 73. Chengdu Baiyu Pharmaceutical Company Information Table 74. Chengdu Baiyu Pharmaceutical Business Overview Table 75. Chengdu Baiyu Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Chengdu Baiyu Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 77. Chengdu Baiyu Pharmaceutical Recent Developments Table 78. Buchang Pharmaceutical Company Information Table 79. Buchang Pharmaceutical Business Overview Table 80. Buchang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Buchang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 82. Buchang Pharmaceutical Recent Developments Table 83. Global Chinese Medicine Injection for Nervous Diseases Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 84. Global Chinese Medicine Injection for Nervous Diseases Sales by Region (2021-2026) & (k units) Table 85. Global Chinese Medicine Injection for Nervous Diseases Sales Market Share by Region (2021-2026) Table 86. Global Chinese Medicine Injection for Nervous Diseases Sales by Region (2027-2032) & (k units) Table 87. Global Chinese Medicine Injection for Nervous Diseases Sales Market Share by Region (2027-2032) Table 88. Global Chinese Medicine Injection for Nervous Diseases Revenue by Region (2021-2026) & (US$ Million) Table 89. Global Chinese Medicine Injection for Nervous Diseases Revenue Market Share by Region (2021-2026) Table 90. Global Chinese Medicine Injection for Nervous Diseases Revenue by Region (2027-2032) & (US$ Million) Table 91. Global Chinese Medicine Injection for Nervous Diseases Revenue Market Share by Region (2027-2032) Table 92. North America Chinese Medicine Injection for Nervous Diseases Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. North America Chinese Medicine Injection for Nervous Diseases Sales by Country (2021-2026) & (k units) Table 94. North America Chinese Medicine Injection for Nervous Diseases Sales by Country (2027-2032) & (k units) Table 95. North America Chinese Medicine Injection for Nervous Diseases Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Chinese Medicine Injection for Nervous Diseases Revenue by Country (2027-2032) & (US$ Million) Table 97. Europe Chinese Medicine Injection for Nervous Diseases Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Europe Chinese Medicine Injection for Nervous Diseases Sales by Country (2021-2026) & (k units) Table 99. Europe Chinese Medicine Injection for Nervous Diseases Sales by Country (2027-2032) & (k units) Table 100. Europe Chinese Medicine Injection for Nervous Diseases Revenue by Country (2021-2026) & (US$ Million) Table 101. Europe Chinese Medicine Injection for Nervous Diseases Revenue by Country (2027-2032) & (US$ Million) Table 102. Asia Pacific Chinese Medicine Injection for Nervous Diseases Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Asia Pacific Chinese Medicine Injection for Nervous Diseases Sales by Country (2021-2026) & (k units) Table 104. Asia Pacific Chinese Medicine Injection for Nervous Diseases Sales by Country (2027-2032) & (k units) Table 105. Asia Pacific Chinese Medicine Injection for Nervous Diseases Revenue by Country (2021-2026) & (US$ Million) Table 106. Asia Pacific Chinese Medicine Injection for Nervous Diseases Revenue by Country (2027-2032) & (US$ Million) Table 107. South America Chinese Medicine Injection for Nervous Diseases Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. South America Chinese Medicine Injection for Nervous Diseases Sales by Country (2021-2026) & (k units) Table 109. South America Chinese Medicine Injection for Nervous Diseases Sales by Country (2027-2032) & (k units) Table 110. South America Chinese Medicine Injection for Nervous Diseases Revenue by Country (2021-2026) & (US$ Million) Table 111. South America Chinese Medicine Injection for Nervous Diseases Revenue by Country (2027-2032) & (US$ Million) Table 112. Middle East and Africa Chinese Medicine Injection for Nervous Diseases Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Middle East and Africa Chinese Medicine Injection for Nervous Diseases Sales by Country (2021-2026) & (k units) Table 114. Middle East and Africa Chinese Medicine Injection for Nervous Diseases Sales by Country (2027-2032) & (k units) Table 115. Middle East and Africa Chinese Medicine Injection for Nervous Diseases Revenue by Country (2021-2026) & (US$ Million) Table 116. Middle East and Africa Chinese Medicine Injection for Nervous Diseases Revenue by Country (2027-2032) & (US$ Million) Table 117. Global Chinese Medicine Injection for Nervous Diseases Sales by Type (2021-2026) & (k units) Table 118. Global Chinese Medicine Injection for Nervous Diseases Sales by Type (2027-2032) & (k units) Table 119. Global Chinese Medicine Injection for Nervous Diseases Sales Market Share by Type (2021-2026) Table 120. Global Chinese Medicine Injection for Nervous Diseases Sales Market Share by Type (2027-2032) Table 121. Global Chinese Medicine Injection for Nervous Diseases Revenue by Type (2021-2026) & (US$ Million) Table 122. Global Chinese Medicine Injection for Nervous Diseases Revenue by Type (2027-2032) & (US$ Million) Table 123. Global Chinese Medicine Injection for Nervous Diseases Revenue Market Share by Type (2021-2026) Table 124. Global Chinese Medicine Injection for Nervous Diseases Revenue Market Share by Type (2027-2032) Table 125. Global Chinese Medicine Injection for Nervous Diseases Price by Type (2021-2026) & (USD/unit) Table 126. Global Chinese Medicine Injection for Nervous Diseases Price by Type (2027-2032) & (USD/unit) Table 127. Global Chinese Medicine Injection for Nervous Diseases Sales by Application (2021-2026) & (k units) Table 128. Global Chinese Medicine Injection for Nervous Diseases Sales by Application (2027-2032) & (k units) Table 129. Global Chinese Medicine Injection for Nervous Diseases Sales Market Share by Application (2021-2026) Table 130. Global Chinese Medicine Injection for Nervous Diseases Sales Market Share by Application (2027-2032) Table 131. Global Chinese Medicine Injection for Nervous Diseases Revenue by Application (2021-2026) & (US$ Million) Table 132. Global Chinese Medicine Injection for Nervous Diseases Revenue by Application (2027-2032) & (US$ Million) Table 133. Global Chinese Medicine Injection for Nervous Diseases Revenue Market Share by Application (2021-2026) Table 134. Global Chinese Medicine Injection for Nervous Diseases Revenue Market Share by Application (2027-2032) Table 135. Global Chinese Medicine Injection for Nervous Diseases Price by Application (2021-2026) & (USD/unit) Table 136. Global Chinese Medicine Injection for Nervous Diseases Price by Application (2027-2032) & (USD/unit) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Chinese Medicine Injection for Nervous Diseases Distributors List Table 140. Chinese Medicine Injection for Nervous Diseases Customers List Table 141. Chinese Medicine Injection for Nervous Diseases Industry Trends Table 142. Chinese Medicine Injection for Nervous Diseases Industry Drivers Table 143. Chinese Medicine Injection for Nervous Diseases Industry Restraints Table 144. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Chinese Medicine Injection for Nervous Diseases Product Image Figure 5. Global Chinese Medicine Injection for Nervous Diseases Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Chinese Medicine Injection for Nervous Diseases Market Size (2021-2032) & (US$ Million) Figure 7. Global Chinese Medicine Injection for Nervous Diseases Sales (2021-2032) & (k units) Figure 8. Global Chinese Medicine Injection for Nervous Diseases Average Price (USD/unit) & (2021-2032) Figure 9. Xueshuantong Injection (Lyophilized) Product Image Figure 10. Xuesetong Injection (Lyophilized) Product Image Figure 11. Ginkgo Biloba Diterpenoids Meglumine Injection Product Image Figure 12. Xingnaojing Injection Product Image Figure 13. Shuxuetong Injection Product Image Figure 14. Danhong Injection Product Image Figure 15. Acanthopanax Senticosus Injection Product Image Figure 16. Other Product Image Figure 17. Secondary Hospital Product Image Figure 18. Tertiary Hospital Product Image Figure 19. Other Product Image Figure 20. Global Chinese Medicine Injection for Nervous Diseases Revenue Share by Manufacturers in 2025 Figure 21. Global Manufacturers of Chinese Medicine Injection for Nervous Diseases, Manufacturing Sites & Headquarters Figure 22. Global Top 5 and 10 Chinese Medicine Injection for Nervous Diseases Players Market Share by Revenue in 2025 Figure 23. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Chinese Medicine Injection for Nervous Diseases Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 25. Global Chinese Medicine Injection for Nervous Diseases Sales by Region in 2025 Figure 26. Global Chinese Medicine Injection for Nervous Diseases Revenue by Region in 2025 Figure 27. North America Chinese Medicine Injection for Nervous Diseases Market Size by Country in 2025 Figure 28. North America Chinese Medicine Injection for Nervous Diseases Sales Market Share by Country (2021-2032) Figure 29. North America Chinese Medicine Injection for Nervous Diseases Revenue Market Share by Country (2021-2032) Figure 30. United States Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Canada Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Mexico Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Europe Chinese Medicine Injection for Nervous Diseases Market Size by Country in 2025 Figure 34. Europe Chinese Medicine Injection for Nervous Diseases Sales Market Share by Country (2021-2032) Figure 35. Europe Chinese Medicine Injection for Nervous Diseases Revenue Market Share by Country (2021-2032) Figure 36. Germany Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. France Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. U.K. Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Italy Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Russia Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Spain Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Netherlands Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Switzerland Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Sweden Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Poland Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Asia Pacific Chinese Medicine Injection for Nervous Diseases Market Size by Country in 2025 Figure 47. Asia Pacific Chinese Medicine Injection for Nervous Diseases Sales Market Share by Country (2021-2032) Figure 48. Asia Pacific Chinese Medicine Injection for Nervous Diseases Revenue Market Share by Country (2021-2032) Figure 49. China Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Japan Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South Korea Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. India Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Australia Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Taiwan Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Southeast Asia Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Southeast Asia Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. South America Chinese Medicine Injection for Nervous Diseases Market Size by Country in 2025 Figure 58. South America Chinese Medicine Injection for Nervous Diseases Sales Market Share by Country (2021-2032) Figure 59. South America Chinese Medicine Injection for Nervous Diseases Revenue Market Share by Country (2021-2032) Figure 60. Brazil Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Argentina Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Chile Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Middle East and Africa Chinese Medicine Injection for Nervous Diseases Market Size by Country in 2025 Figure 64. Middle East and Africa Chinese Medicine Injection for Nervous Diseases Sales Market Share by Country (2021-2032) Figure 65. Middle East and Africa Chinese Medicine Injection for Nervous Diseases Revenue Market Share by Country (2021-2032) Figure 66. Egypt Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. South Africa Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Israel Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Türkiye Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. GCC Countries Chinese Medicine Injection for Nervous Diseases Revenue Growth Rate (2021-2032) & (US$ Million) Figure 71. Global Chinese Medicine Injection for Nervous Diseases Sales Market Share by Type (2021-2032) Figure 72. Global Chinese Medicine Injection for Nervous Diseases Revenue Market Share by Type (2021-2032) Figure 73. Global Chinese Medicine Injection for Nervous Diseases Price (USD/unit) by Type (2021-2032) Figure 74. Global Chinese Medicine Injection for Nervous Diseases Sales Market Share by Application (2021-2032) Figure 75. Global Chinese Medicine Injection for Nervous Diseases Revenue Market Share by Application (2021-2032) Figure 76. Global Chinese Medicine Injection for Nervous Diseases Price (USD/unit) by Application (2021-2032) Figure 77. Chinese Medicine Injection for Nervous Diseases Value Chain Figure 78. Chinese Medicine Injection for Nervous Diseases Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Chinese Medicine Injection for Nervous Diseases Industry Opportunities and Challenges

Scope & coverage.

Types
  • Xueshuantong Injection (Lyophilized)
  • Xuesetong Injection (Lyophilized)
  • Ginkgo Biloba Diterpenoids Meglumine Injection
  • Xingnaojing Injection
  • Shuxuetong Injection
  • Danhong Injection
  • Acanthopanax Senticosus Injection
  • Other
Applications
  • Secondary Hospital
  • Tertiary Hospital
  • Other
Companies covered
  • ZBD Pharmaceutical
  • Yunnan Biovalley Pharmaceutical
  • Wuzhou Pharmaceutical
  • Tasly Pharmaceuticals
  • Shenyang Shuangding Pharmaceutical
  • Mudanjiang Youbo Pharmaceutical
  • Kunming Longjin Pharmaceutical
  • Kanion Pharmaceutical
  • Jinling Pharmaceutical
  • Jemincare
  • Heilongjiang Wusulijiang Pharmaceutical
  • Chengdu Baiyu Pharmaceutical
  • Buchang Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Chinese Medicine Injection for Nervous Diseases Market Size (2021-2032)
  4. 2.2.2 Global Chinese Medicine Injection for Nervous Diseases Sales (2021-2032)
  5. 2.2.3 Global Chinese Medicine Injection for Nervous Diseases Market Average Price (2021-2032)
  6. 2.3 Chinese Medicine Injection for Nervous Diseases by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Xueshuantong Injection (Lyophilized)
  9. 2.3.3 Xuesetong Injection (Lyophilized)
  10. 2.3.4 Ginkgo Biloba Diterpenoids Meglumine Injection
  11. 2.3.5 Xingnaojing Injection
  12. 2.3.6 Shuxuetong Injection
  13. 2.3.7 Danhong Injection
  14. 2.3.8 Acanthopanax Senticosus Injection
  15. 2.3.9 Other
  16. 2.4 Chinese Medicine Injection for Nervous Diseases by Application
  17. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  18. 2.4.2 Secondary Hospital
  19. 2.4.3 Tertiary Hospital
  20. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Chinese Medicine Injection for Nervous Diseases Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Chinese Medicine Injection for Nervous Diseases Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Chinese Medicine Injection for Nervous Diseases Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Chinese Medicine Injection for Nervous Diseases Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Chinese Medicine Injection for Nervous Diseases Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Chinese Medicine Injection for Nervous Diseases, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Chinese Medicine Injection for Nervous Diseases, Product Type & Application
  8. 3.8 Global Manufacturers of Chinese Medicine Injection for Nervous Diseases, Established Date
  9. 3.9 Global Chinese Medicine Injection for Nervous Diseases Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 ZBD Pharmaceutical
  2. 4.1.1 ZBD Pharmaceutical Company Information
  3. 4.1.2 ZBD Pharmaceutical Business Overview
  4. 4.1.3 ZBD Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 ZBD Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  6. 4.1.5 ZBD Pharmaceutical Recent Developments
  7. 4.2 Yunnan Biovalley Pharmaceutical
  8. 4.2.1 Yunnan Biovalley Pharmaceutical Company Information
  9. 4.2.2 Yunnan Biovalley Pharmaceutical Business Overview
  10. 4.2.3 Yunnan Biovalley Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Yunnan Biovalley Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  12. 4.2.5 Yunnan Biovalley Pharmaceutical Recent Developments
  13. 4.3 Wuzhou Pharmaceutical
  14. 4.3.1 Wuzhou Pharmaceutical Company Information
  15. 4.3.2 Wuzhou Pharmaceutical Business Overview
  16. 4.3.3 Wuzhou Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Wuzhou Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  18. 4.3.5 Wuzhou Pharmaceutical Recent Developments
  19. 4.4 Tasly Pharmaceuticals
  20. 4.4.1 Tasly Pharmaceuticals Company Information
  21. 4.4.2 Tasly Pharmaceuticals Business Overview
  22. 4.4.3 Tasly Pharmaceuticals Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Tasly Pharmaceuticals Chinese Medicine Injection for Nervous Diseases Product Portfolio
  24. 4.4.5 Tasly Pharmaceuticals Recent Developments
  25. 4.5 Shenyang Shuangding Pharmaceutical
  26. 4.5.1 Shenyang Shuangding Pharmaceutical Company Information
  27. 4.5.2 Shenyang Shuangding Pharmaceutical Business Overview
  28. 4.5.3 Shenyang Shuangding Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Shenyang Shuangding Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  30. 4.5.5 Shenyang Shuangding Pharmaceutical Recent Developments
  31. 4.6 Mudanjiang Youbo Pharmaceutical
  32. 4.6.1 Mudanjiang Youbo Pharmaceutical Company Information
  33. 4.6.2 Mudanjiang Youbo Pharmaceutical Business Overview
  34. 4.6.3 Mudanjiang Youbo Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Mudanjiang Youbo Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  36. 4.6.5 Mudanjiang Youbo Pharmaceutical Recent Developments
  37. 4.7 Kunming Longjin Pharmaceutical
  38. 4.7.1 Kunming Longjin Pharmaceutical Company Information
  39. 4.7.2 Kunming Longjin Pharmaceutical Business Overview
  40. 4.7.3 Kunming Longjin Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Kunming Longjin Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  42. 4.7.5 Kunming Longjin Pharmaceutical Recent Developments
  43. 4.8 Kanion Pharmaceutical
  44. 4.8.1 Kanion Pharmaceutical Company Information
  45. 4.8.2 Kanion Pharmaceutical Business Overview
  46. 4.8.3 Kanion Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Kanion Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  48. 4.8.5 Kanion Pharmaceutical Recent Developments
  49. 4.9 Jinling Pharmaceutical
  50. 4.9.1 Jinling Pharmaceutical Company Information
  51. 4.9.2 Jinling Pharmaceutical Business Overview
  52. 4.9.3 Jinling Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Jinling Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  54. 4.9.5 Jinling Pharmaceutical Recent Developments
  55. 4.10 Jemincare
  56. 4.10.1 Jemincare Company Information
  57. 4.10.2 Jemincare Business Overview
  58. 4.10.3 Jemincare Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Jemincare Chinese Medicine Injection for Nervous Diseases Product Portfolio
  60. 4.10.5 Jemincare Recent Developments
  61. 4.11 Heilongjiang Wusulijiang Pharmaceutical
  62. 4.11.1 Heilongjiang Wusulijiang Pharmaceutical Company Information
  63. 4.11.2 Heilongjiang Wusulijiang Pharmaceutical Business Overview
  64. 4.11.3 Heilongjiang Wusulijiang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Heilongjiang Wusulijiang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  66. 4.11.5 Heilongjiang Wusulijiang Pharmaceutical Recent Developments
  67. 4.12 Chengdu Baiyu Pharmaceutical
  68. 4.12.1 Chengdu Baiyu Pharmaceutical Company Information
  69. 4.12.2 Chengdu Baiyu Pharmaceutical Business Overview
  70. 4.12.3 Chengdu Baiyu Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Chengdu Baiyu Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  72. 4.12.5 Chengdu Baiyu Pharmaceutical Recent Developments
  73. 4.13 Buchang Pharmaceutical
  74. 4.13.1 Buchang Pharmaceutical Company Information
  75. 4.13.2 Buchang Pharmaceutical Business Overview
  76. 4.13.3 Buchang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Buchang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  78. 4.13.5 Buchang Pharmaceutical Recent Developments
5 Global Chinese Medicine Injection for Nervous Diseases Market Scenario by Region
  1. 5.1 Global Chinese Medicine Injection for Nervous Diseases Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Chinese Medicine Injection for Nervous Diseases Sales by Region: 2021-2032
  3. 5.2.1 Global Chinese Medicine Injection for Nervous Diseases Sales by Region: 2021-2026
  4. 5.2.2 Global Chinese Medicine Injection for Nervous Diseases Sales by Region: 2027-2032
  5. 5.3 Global Chinese Medicine Injection for Nervous Diseases Revenue by Region: 2021-2032
  6. 5.3.1 Global Chinese Medicine Injection for Nervous Diseases Revenue by Region: 2021-2026
  7. 5.3.2 Global Chinese Medicine Injection for Nervous Diseases Revenue by Region: 2027-2032
  8. 5.4 North America Chinese Medicine Injection for Nervous Diseases Market Facts & Figures by Country
  9. 5.4.1 North America Chinese Medicine Injection for Nervous Diseases Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Chinese Medicine Injection for Nervous Diseases Sales by Country (2021-2032)
  11. 5.4.3 North America Chinese Medicine Injection for Nervous Diseases Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Chinese Medicine Injection for Nervous Diseases Market Facts & Figures by Country
  16. 5.5.1 Europe Chinese Medicine Injection for Nervous Diseases Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Chinese Medicine Injection for Nervous Diseases Sales by Country (2021-2032)
  18. 5.5.3 Europe Chinese Medicine Injection for Nervous Diseases Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Chinese Medicine Injection for Nervous Diseases Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Chinese Medicine Injection for Nervous Diseases Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Chinese Medicine Injection for Nervous Diseases Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Chinese Medicine Injection for Nervous Diseases Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Chinese Medicine Injection for Nervous Diseases Market Facts & Figures by Country
  41. 5.7.1 South America Chinese Medicine Injection for Nervous Diseases Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Chinese Medicine Injection for Nervous Diseases Sales by Country (2021-2032)
  43. 5.7.3 South America Chinese Medicine Injection for Nervous Diseases Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Chinese Medicine Injection for Nervous Diseases Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Chinese Medicine Injection for Nervous Diseases Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Chinese Medicine Injection for Nervous Diseases Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Chinese Medicine Injection for Nervous Diseases Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Chinese Medicine Injection for Nervous Diseases Sales by Type (2021-2032)
  2. 6.1.1 Global Chinese Medicine Injection for Nervous Diseases Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Chinese Medicine Injection for Nervous Diseases Sales Market Share by Type (2021-2032)
  4. 6.2 Global Chinese Medicine Injection for Nervous Diseases Revenue by Type (2021-2032)
  5. 6.2.1 Global Chinese Medicine Injection for Nervous Diseases Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Chinese Medicine Injection for Nervous Diseases Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Chinese Medicine Injection for Nervous Diseases Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Chinese Medicine Injection for Nervous Diseases Sales by Application (2021-2032)
  2. 7.1.1 Global Chinese Medicine Injection for Nervous Diseases Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Chinese Medicine Injection for Nervous Diseases Sales Market Share by Application (2021-2032)
  4. 7.2 Global Chinese Medicine Injection for Nervous Diseases Revenue by Application (2021-2032)
  5. 7.2.1 Global Chinese Medicine Injection for Nervous Diseases Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Chinese Medicine Injection for Nervous Diseases Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Chinese Medicine Injection for Nervous Diseases Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Chinese Medicine Injection for Nervous Diseases Value Chain Analysis
  2. 8.1.1 Chinese Medicine Injection for Nervous Diseases Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Chinese Medicine Injection for Nervous Diseases Production Mode & Process
  5. 8.2 Chinese Medicine Injection for Nervous Diseases Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Chinese Medicine Injection for Nervous Diseases Distributors
  8. 8.2.3 Chinese Medicine Injection for Nervous Diseases Customers
9 Global Chinese Medicine Injection for Nervous Diseases Analyzing Market Dynamics
  1. 9.1 Chinese Medicine Injection for Nervous Diseases Industry Trends
  2. 9.2 Chinese Medicine Injection for Nervous Diseases Industry Drivers
  3. 9.3 Chinese Medicine Injection for Nervous Diseases Industry Opportunities and Challenges
  4. 9.4 Chinese Medicine Injection for Nervous Diseases Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research